Correlation of C-reactive protein with clinical and endoscopic activity in patients with ulcerative colitis

Digestive Diseases and Sciences

Volumn 56, Issue 6, 2011, Pages 1801-1805

  Karoui, Sami ^a   Laz, Sonia ^a   Serghini, Meriem ^a   Bibani, Norsaf ^a   Boubaker, Jalel ^a   Filali, Azza ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

C Reactive protein; Ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; COLONOSCOPY; DISEASE ACTIVITY INDEX; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RACHMILEWITZ SCORE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 79959693355     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-010-1496-7     Document Type: Article

References (17)

1. Stange EF, Travis SPL, Vermeire S, et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn Colitis. 2008;2:1-23. (Pubitemid 351179487)
2. Naber AHJ, De Jong DJ. Assessment of disease activity in inflammatory bowel disease: Relevance for clinical trials. Neth J Med. 2003;61:105-110. (Pubitemid 39089380)
3. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in inflammatory bowel disease: Useful, magic or unnecessary tools? Gut. 2006;55:426-431.
4. Karoui S, Serghini M, Boubaker J, Filali A. C-reactive protein: A useful tool for evaluation of clinical activity in inflammatory bowel disease? In Nagasawa S (ed) C-reactive protein: new research. Nova Science Publisher, New York. 2009:43-49.
5. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomised study. N Engl J Med. 1987;317: 1625-1629. (Pubitemid 18010466)
6. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J. 1989;298:82-86. (Pubitemid 19032930)
7. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterlogy. Can J Gastroenterol. 2005;19: 5A-36A.
8. Mehdi A, Baccouche A, Skandrani K, et al. Epidémiologie des maladies inflammatoires chroniques de l'intestin dans le centreest tunisien. Maghreb Médical. 1997;314:47-52.
9. Crama-Bohbouth G, Pena AS, Biemond I, et al. Are activity indices useful in assessing active intestinal inflammation in Crohn's disease? Gut. 1989;30:1236-1240.
10. Tall AR. C-reactive protein reassessed. N Engl J Med. 2004;350:1450-1452. (Pubitemid 38420000)
11. Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:661-665. (Pubitemid 39276479)
12. Karoui S, Ouerdiane S, Serghini M, et al. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease. Dig Liver Dis. 2007;39:1006-1010. (Pubitemid 350018697)
13. Solem CA, Loftus EV Jr, Tremaine WJ, et al. Correlation of C-reactive protein with clinical, endoscopic, histologic and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:707-712. (Pubitemid 41271173)
14. Schoepfer AM, Beglinger C, Straumann A, Trummler M, Renzulli P, Seibold F. Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis. 2009;15:1851-1858.
15. Osada T, Ohkusa T, Okayasu I, et al. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. J Gastroenterol Hepatol. 2008;23(2):S262-S267.
16. Henriksen M, Jahnsen J, Lygren I, et al. C-reactive protein: A predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut. 2008;57:1518-1523.
17. Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008;103:162-169.